IP Library Patent Application 12171526
Patent Application
App. No. 12/171,526

T1R3 A NOVEL TASTE RECEPTOR

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/171,526
Abstract

The present invention relates to the discovery, identification and characterization of a receptor protein, referred to herein as T1R3, which is expressed in taste receptor cells and associated with the perception of bitter and sweet taste. The invention encompasses T1R3 nucleotides, host cell expression systems, T1R3 proteins, fusion protein, transgenic animals that express a T1R3 transgene, and recombinant “knock-out” animals that do not express T1R3. The invention further relates to methods for identifying modulators of the T1R3-mediated taste response and the use of such modulators to either inhibit or promote the perception of bitterness or sweetness. The modulators of T1R3 activity may be used as flavor enhancers in food, beverages and pharmaceuticals.

Claims (6)

1 . A method for identifying an inhibitor of T1R3 in vivo comprising:

(i) offering a test animal an opportunity to consume separately (a) a composition comprising a sweet tastant and (b) the composition further comprising a test inhibitor; and

(ii) comparing the amount of consumption of the compositions according to (a) and (b), wherein greater consumption of the composition according to (a) has a positive correlation with an ability of the test inhibitor to inhibit T1R3.

2 . A method for identifying an activator of T1R3 in vivo comprising:

(i) offering a test animal an opportunity to consume separately (a) a composition and (b) the composition further comprising a test activator; and

(ii) comparing the amount of consumption of the compositions according to (a) and (b), wherein greater consumption of the composition according to (b) has a positive correlation with an ability of the test activator to activate T1R3.

Assignments (1)
CONFIRMATORY LICENSE Recorded Apr 16, 2010
From: MOUNT SINAI SCHOOL OF MEDICINE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024242/0814 →